Axonics Inc

Market cap: $3,529,947,321

Exchange: NAS

Sector: Health Technology

Axonics Modulation Technologies, Inc. operates as a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation solutions. The firm focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company was founded by Guang Qiang Jiang, Danny L. Dearen, Timothy Deer, and Michael V. Williamson in March 2012 and is headquartered in Irvine, CA.

Key Statistics

Company Name

Axonics Inc

Average Volume (10 days)

1,016,544

Average Volume (30 days)

805,702

Moving Average (50 days)

$68.1

Moving Average (200 days)

$61.24

Ex-Divided Date

n/a

Dividend Yield

0

P/E Ratio

-579.8205

Market Cap

3,529,947,321

Shares Outstanding

51,003,429

52-Week High Split Adjust Only

69.68

52-Week Low Split Adjust Only

47.59

Employee Count

353

Beta

1.2536

Next Earnings Date

2024-04-29

TTM Dividend Rate Per Share

0

Price Changes

Past 5 days

0.01%

Past 30 days

0.02%

Past 3 months

0.11%

Past 6 months

0.23%

Past year

0.27%

Past 2 years

0.07%

Past 5 years

1.97%

Max % Change

3.62%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Axonics IncAXNXn/an/a-31.6n/an/a
Peer AvgN/An/an/a-4.5n/an/a
Outset Medical IncOMn/an/a-17.8n/an/a